<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Act 1934
Date of Report (Date of earliest event reported) May 20, 1996
------------
Respironics, Inc.
-----------------
(Exact name of registrant as specified in its charter)
<TABLE>
<CAPTION>
<S> <C> <C>
Delaware 000-16723 25-1304989
- --------------------------------------------------------------
State or other jurisdiction Commission IRS Employer
of incorporation File Number identification
</TABLE>
1001 Murry Ridge Drive, Murrysville, PA 15668
- --------------------------------------------------------------
(Address of principal executive officers) (Zip)
Registrant's telephone number, including area code (412) 733-0200
-------------------
------------------------------------------------------------------------
(Former name and former address, if changed since last report)
<PAGE>
Item 1. Changes in Control of Registrant.
None
Item 2. Acquisition or Disposition of Assets.
None
Item 3. Bankruptcy or Receivership.
None
Item 4. Changes in Registrant's Certifying Accountant.
None
Item 5. Other Events.
On May 8, 1996, Daniel J. Bevevino was elected to the position
of Vice President and Chief Financial Officer (see attached).
Item 6. Resignation of Registrant's Directors.
None
Item 7. Financial Statements and Exhibits.
None
<PAGE>
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Respironics, Inc.
-----------------------------
(Registrant)
5-20-96 /s/ Dorita A. Pishko
- ---------------- -----------------------------
(Date) (Signature)
Dorita A. Pishko
Corporate Secretary
<PAGE>
PRESS RELEASE
Contact: Dorita A. Pishko
Respironics, Inc.
(412) 733-0209
RESPIRONICS DIRECTORS ELECT VICE PRESIDENT
------------------------------------------
MURRYSVILLE, PA, MAY 8, 1996 - RESPIRONICS, INC. (NASDAQ/NMS SYMBOL:RESP)
announced that Daniel J. Bevevino, 37, was elected to the position of vice
president and chief financial officer at today's Board of Directors meeting in
Pittsburgh.
Following five years with the international accounting firm of Ernst & Young
where his audit experience included a significant concentration on healthcare
companies, Mr. Bevevino joined Respironics in 1988 as manager, cost accounting.
He was elected corporate controller two years later and, in late 1994, was named
to the additional position of chief financial officer.
A Certified Public Accountant, Mr. Bevevino is a 1981 graduate of the Duquesne
University School of Business. He was awarded a Masters degree in business
administration in 1988 by the University of Notre Dame.
Respironics, Inc. designs, develops, manufactures and sells respiratory medical
products for use in the home, hospitals, and in emergency care situations. Late
in January, the company announced that it has been awarded ISO 9001
certification from the International Organization of Standardization, a Geneva,
Switzerland-based quality standards organization.
# # #
